Day: October 3, 2020

Maha Energy AB: Announce September Production Volumes and extends invitation to Annual Investor Presentation 7 October

Maha Energy AB (publ)Strandvägen 5ASE-114 51 Stockholmwww.mahaenergy.caPress releaseStockholmOctober 3, 2020Maha Energy AB (publ) Announce September Production Volumes and extends invitation to Annual Investor Presentation 7 October.Production VolumesThe Company’s aggregate sales production for the month of September totaled 89,7121 barrels of oil and 47.543 million scf of gas for a combined average production of approximately 3,255 BOE/day2, before royalties and taxes.During the month of September the dual GTE-4 oil producing well was shut down for 14 days, due to workover operations to fish a stuck blanking sleeve in the Agua Grande (AG) short string.  Fishing operations to date have been unsuccessful and a more rigorous workover operation is now scheduled during the fourth quarter to restore production from the AG zone.  Production...

Continue reading

Apellis Announces New Analysis Demonstrating Targeted C3 Therapy Pegcetacoplan Slows Progression of Early Disease in Patients with Geographic Atrophy (GA)

Post hoc analysis of Phase 2 FILLY study shows 39% reduction in rate of progression from nascent GA, an earlier form of disease, to GA in patients treated with pegcetacoplan monthly vs. shamFirst ever observation of slowed nascent GA progression in a Phase 2 study signals potential benefit of earlier intervention with pegcetacoplan in patients with GAData support hypothesis that targeting C3 with pegcetacoplan addresses an underlying cause of disease, excessive complement activation, as evidenced by slowed progression of nascent GA to GAWALTHAM, Mass., Oct. 03, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced the results of a post hoc analysis of the Phase 2 FILLY study investigating intravitreal pegcetacoplan (APL-2) for...

Continue reading

MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)

Data presented at EURETINA 2020 Virtual Congress show sustained improvements in retinal sensitivity at nine monthsSignificant improvements were also demonstrated in the time taken to walk through a vision-guided mobility maze at nine monthsLONDON and NEW YORK, Oct. 03, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced nine-month data from the ongoing Phase 1/2 clinical trial (NCT03252847) of AAV-RPGR, an investigational gene therapy in development for the treatment of patients with X-linked retinitis pigmentosa (XLRP). Data presented today at the EURETINA 2020 Virtual Congress demonstrated significant improvement in vision-guided mobility and retinal sensitivity in treated eyes compared to untreated eyes nine months after treatment.MeiraGTx...

Continue reading

Termination of Liquidity Provider Agreement

Company Announcement no. 65 – 2020Copenhagen, October 03rd, 2020Termination of Liquidity Provider AgreementGreenMobility has terminated the Liquidity Provider Agreement with Arbejdernes Landsbank.Arbejdernes Landsbank will continue to act as market maker up to and including 16 October 2020.For further information:Anders Wall, VP Investor Relations GreenMobility, phone: +45 2540 3020, mail: aw@greenmobility.comGreenMobility A/S, Landgreven 3, 1301 København K, CVR: 35521585, www.greenmobility.comCertified AdvisorNORDEN CEF ApSJohn NordenKongevejen 365, DK-2840 Holte+45 2072 0200jn@nordencef.dkGreenMobility offers modern urbanites easy, flexible and sustainable transport in the form of electric, shared city cars. Users have access to these cars via the GreenMobility app. Trips are paid per-minute. Today, GreenMobility operates 400 EVs in...

Continue reading

Redwood Capital Management Limited:Stocks rose for two straight days with Techs lead as Market wraps

Major stocks led by Tech giants ended up higher on the opening of the last quarter this year. Visa had been the biggest contributors on the Dows increase, while technology related stocks pull Nasdaq up by 1.4%. Investors are still eyeing that a positive deal will be grant from the lawmakers and the White House with regards additional fiscal-stimulus package which will weigh down a bit the pressure on the US economy. House Speaker Nancy Pelosi stated that they are about to move forward and have a vote whether to pass the $2.2 trillion coronavirus stimulus proposal from House Democrats or not. She said in a public conference, “I’m hoping that we will be voting on it today,” and added, “We’re hopeful that we can reach agreement because the needs of the American people are so great — But there has to be a recognition that it takes money...

Continue reading

Elite Capital International: Major Indices ended up higher getting hope from Stimulus package

Major stocks rose getting back few points loss from yesterday’s bout after investors saw positive developments among congressional lawmakers to push further fiscal stimulus. S&P 500 and Nasdaq Composite both increased about 0.82%, while, the Dow was appraised by 1.20%. Additional cause of the sudden surge is that most investors are now getting high optimism from the labor report that shows more payrolls are now back on the list in September which means that the economy is now stepping into recovery. Meanwhile, here are the main movements in the Global Stock Market this Wednesday; Stocks – S&P 500 increased a bit about 27.43 points or almost 1% higher to 3,362.90 as market ended at 4 p.m. of New yorks time.– The Dow Jones Industrial Average surge about 329.70 points or 1.20% higher to 27,782.36.– Nasdaq Composite...

Continue reading

A.I.S. Resources Announces Grant of Options

VANCOUVER, British Columbia, Oct. 02, 2020 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSX-V – AIS, OTCQB: AISSF) (the “Company” or “AIS”) announces that the Company has granted a total of 1,550.000 incentive stock options to various directors of the Company in accordance with the Company’s stock option plan. Each Option is exercisable into one common share of the Company at a price of $0.075 per Share being the closing price of the Shares on the TSX Venture Exchange on October 2, 2020. The Options vested on grant and will expire on October 2, 2025.The stock options granted are subject to the acceptance of the TSX Venture Exchange.About A.I.S. Resources LimitedA.I.S. Resources Ltd. is a publicly traded investment issuer listed on the TSX Venture Exchange focused on precious and base metals exploration. The Company is managed by...

Continue reading